Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | DiseaseId | DiseaseName | DiseaseMIM | ConceptID | Source | Typical association | HGMD variants | ClinVar variants | HGNC ID | GeneMIM |
---|
HPO disease - gene - phenotype typical associations: |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | AKT1 CL E G H | 207 | 744 | Aortic valves stenosis of the child | | | ORPHA | 1 | | 758 | 391 | 164730 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | ALS2 CL E G H | 57679 | 300605 | Juvenile amyotrophic lateral sclerosis | | CN239582 | ORPHA | 1 | | 947 | 443 | 606352 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | AP4E1 CL E G H | 23431 | 613744 | Spastic paraplegia 51, autosomal recessive | 613744 | C3151056 | OMIM | 1 | | 509 | 573 | 607244 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | ASAH1 CL E G H | 427 | 333 | | | | ORPHA | 1 | | 913 | 735 | 613468 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | ATP6V0A2 CL E G H | 23545 | 357074 | | | | ORPHA | 1 | | 610 | 18481 | 611716 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | ATP6V0A2 CL E G H | 23545 | 2834 | | | | ORPHA | 1 | | 610 | 18481 | 611716 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | ATP6V1A CL E G H | 523 | 357074 | | | | ORPHA | 1 | | 229 | 851 | 607027 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | ATP6V1E1 CL E G H | 529 | 357074 | | | | ORPHA | 1 | | 196 | 857 | 108746 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | CHRNE CL E G H | 1145 | 608931 | Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency | 608931 | C1837091 | OMIM | 1 | | 1011 | 1966 | 100725 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | COLQ CL E G H | 8292 | 603034 | Endplate acetylcholinesterase deficiency | 603034 | C1864233 | OMIM | 1 | | 542 | 2226 | 603033 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | CPLX1 CL E G H | 10815 | 194190 | 4p partial monosomy syndrome | 194190 | C1956097 | OMIM | 1 | | 206 | 2309 | 605032 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | CTBP1 CL E G H | 1487 | 194190 | 4p partial monosomy syndrome | 194190 | C1956097 | OMIM | 1 | | 352 | 2494 | 602618 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | ECEL1 CL E G H | 9427 | 615065 | Distal arthrogryposis type 5D | 615065 | C3554415 | OMIM | 1 | | 213 | 3147 | 605896 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | FBN1 CL E G H | 2200 | 154700 | Marfan syndrome | 154700 | C0024796 | OMIM | 1 | | 6619 | 3603 | 134797 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | FGFRL1 CL E G H | 53834 | 194190 | 4p partial monosomy syndrome | 194190 | C1956097 | OMIM | 1 | | 396 | 3693 | 605830 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | FUCA1 CL E G H | 2517 | 349 | Neuroaxonal dystrophy renal tubular acidosis | | | ORPHA | 1 | | 308 | 4006 | 612280 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | FUS CL E G H | 2521 | 300605 | Juvenile amyotrophic lateral sclerosis | | CN239582 | ORPHA | 1 | | 474 | 4010 | 137070 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | FUZ CL E G H | 80199 | 3027 | Iris dysplasia hypertelorism deafness | | | ORPHA | 1 | | 57 | 26219 | 610622 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | G6PC CL E G H | 2538 | 232200 | Glycogen storage disease type 1A | 232200 | C2919796 | OMIM | 1 | | | 4056 | 613742 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | GFPT1 CL E G H | 2673 | 608931 | Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency | 608931 | C1837091 | OMIM | 1 | | 524 | 4241 | 138292 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | GYG1 CL E G H | 2992 | 263297 | | | | ORPHA | 1 | | 273 | 4699 | 603942 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | HERC2 CL E G H | 8924 | 176270 | Prader-Willi syndrome | 176270 | C0032897 | OMIM | 1 | | 936 | 4868 | 605837 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | HSD17B4 CL E G H | 3295 | 261515 | Bifunctional peroxisomal enzyme deficiency | 261515 | C0342870 | OMIM | 1 | | 983 | 5213 | 601860 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | IPW CL E G H | 3653 | 176270 | Prader-Willi syndrome | 176270 | C0032897 | OMIM | 1 | | 302 | 6109 | 601491 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | LAS1L CL E G H | 81887 | 309585 | Wilson-Turner X-linked mental retardation syndrome | 309585 | C1839736 | OMIM | 1 | | 283 | 25726 | 300964 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | LETM1 CL E G H | 3954 | 194190 | 4p partial monosomy syndrome | 194190 | C1956097 | OMIM | 1 | | 367 | 6556 | 604407 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | MAGEL2 CL E G H | 54551 | 176270 | Prader-Willi syndrome | 176270 | C0032897 | OMIM | 1 | | 1013 | 6814 | 605283 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | MKRN3 CL E G H | 7681 | 176270 | Prader-Willi syndrome | 176270 | C0032897 | OMIM | 1 | | 357 | 7114 | 603856 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | MKRN3-AS1 CL E G H | 10108 | 176270 | Prader-Willi syndrome | 176270 | C0032897 | OMIM | 1 | | | 12910 | 603857 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | NDN CL E G H | 4692 | 176270 | Prader-Willi syndrome | 176270 | C0032897 | OMIM | 1 | | 328 | 7675 | 602117 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | NPAP1 CL E G H | 23742 | 176270 | Prader-Willi syndrome | 176270 | C0032897 | OMIM | 1 | | 387 | 1190 | 610922 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | NSD2 CL E G H | 7468 | 194190 | 4p partial monosomy syndrome | 194190 | C1956097 | OMIM | 1 | | 538 | 12766 | 602952 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | PANK2 CL E G H | 80025 | 234200 | Pigmentary pallidal degeneration | 234200 | C0018523 | OMIM | 1 | | 499 | 15894 | 606157 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | PIEZO2 CL E G H | 63895 | 376 | | | | ORPHA | 1 | | 978 | 26270 | 613629 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | PIEZO2 CL E G H | 63895 | 114300 | Gordon's syndrome | 114300 | C0220666 | OMIM | 1 | | 978 | 26270 | 613629 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | PIEZO2 CL E G H | 63895 | 248700 | Marden-Walker syndrome | 248700 | C0796033 | OMIM | 1 | | 978 | 26270 | 613629 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | PIEZO2 CL E G H | 63895 | 108145 | Oculomelic amyoplasia | 108145 | C1862472 | OMIM | 1 | | 978 | 26270 | 613629 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | PTEN CL E G H | 5728 | 744 | Aortic valves stenosis of the child | | | ORPHA | 1 | | 3012 | 9588 | 601728 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | PWAR1 CL E G H | 145624 | 176270 | Prader-Willi syndrome | 176270 | C0032897 | OMIM | 1 | | 303 | 30089 | 600161 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | PWRN1 CL E G H | 791114 | 176270 | Prader-Willi syndrome | 176270 | C0032897 | OMIM | 1 | | 314 | 33235 | 611215 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | RUSC2 CL E G H | 9853 | 617773 | MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61 | 617773 | C4540424 | OMIM | 1 | | 824 | 23625 | 611053 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | SIGMAR1 CL E G H | 10280 | 300605 | Juvenile amyotrophic lateral sclerosis | | CN239582 | ORPHA | 1 | | 247 | 8157 | 601978 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | SMS CL E G H | 6611 | 309583 | Snyder Robinson syndrome | 309583 | C0796160 | OMIM | 1 | | 294 | 11123 | 300105 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | SNORD115-1 CL E G H | 338433 | 176270 | Prader-Willi syndrome | 176270 | C0032897 | OMIM | 1 | | 305 | 33020 | 609837 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | SNORD116-1 CL E G H | 100033413 | 176270 | Prader-Willi syndrome | 176270 | C0032897 | OMIM | 1 | | 305 | 33067 | 605436 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | SNRPN CL E G H | 6638 | 176270 | Prader-Willi syndrome | 176270 | C0032897 | OMIM | 1 | | 396 | 11164 | 182279 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | SPARC CL E G H | 6678 | 616507 | Osteogenesis imperfecta, type xvii | 616507 | C4225301 | OMIM | 1 | | 168 | 11219 | 182120 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | SPG11 CL E G H | 80208 | 300605 | Juvenile amyotrophic lateral sclerosis | | CN239582 | ORPHA | 1 | | 2625 | 11226 | 610844 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | TBC1D20 CL E G H | 128637 | 615663 | Warburg micro syndrome 4 | 615663 | C3810265 | OMIM | 1 | | 195 | 16133 | 611663 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | TGFB3 CL E G H | 7043 | 615582 | Loeys-Dietz syndrome 5 | 615582 | C3810012 | OMIM | 1 | | 551 | 11769 | 190230 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | TRIM2 CL E G H | 23321 | 615490 | Charcot-Marie-Tooth disease, axonal, type 2R | 615490 | C3809655 | OMIM | 1 | | 404 | 15974 | 614141 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | VANGL1 CL E G H | 81839 | 3027 | Iris dysplasia hypertelorism deafness | | | ORPHA | 1 | | 278 | 15512 | 610132 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | WHCR CL E G H | 7467 | 194190 | 4p partial monosomy syndrome | 194190 | C1956097 | OMIM | 1 | | | 12764 | 0 |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | FSHB CL E G H | 2488 | 229070 | Follicle-stimulating hormone deficiency, isolated | 229070 | C1856716 | OMIM | 0 | | 71 | 3964 | 136530 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | MAP3K7 CL E G H | 6885 | 617137 | Frontometaphyseal dysplasia 2 | 617137 | C4310697 | OMIM | 0 | | 235 | 6859 | 602614 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | MECP2 CL E G H | 4204 | 778 | | | | ORPHA | 0 | | 1925 | 6990 | 300005 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | POLG CL E G H | 5428 | 298 | Mitochondrial neurogastrointestinal encephalomyopathy | | CN918676 | ORPHA | 0 | | 2324 | 9179 | 174763 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | RRM2B CL E G H | 50484 | 298 | Mitochondrial neurogastrointestinal encephalomyopathy | | CN918676 | ORPHA | 0 | | 354 | 17296 | 604712 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | SLC9A6 CL E G H | 10479 | 85278 | | | | ORPHA | 0 | | 612 | 11079 | 300231 |
HP:0003199 | HP:0003199 | Decreased muscle mass | 0 | TYMP CL E G H | 1890 | 298 | Mitochondrial neurogastrointestinal encephalomyopathy | | CN918676 | ORPHA | 0 | | 895 | 3148 | 131222 |